Cellectis (CLLS) Free Cash Flow (2015 - 2026)
Cellectis (CLLS) posted Free Cash Flow of -$15.1 million for Q1 2026, down 23.72% on a QoQ basis from -$12.2 million in Q4 2025, and up 9.66% year-over-year from -$13.8 million in Q1 2025.
Cellectis (CLLS) has 12 years of Free Cash Flow data on file, last reported at -$15.1 million in Q1 2026.
- In Q1 2026, Free Cash Flow rose 9.66% year-over-year to -$15.1 million; the TTM figure through Mar 2026 stood at -$37.8 million (down 241.3% YoY), while the FY2025 annual figure was -$39.4 million, down 293.09% from the prior year.
- Free Cash Flow declined to -$15.1 million in Q1 2026, from -$12.2 million in the prior quarter.
- Across five years, Free Cash Flow topped out at $53.2 million in Q2 2024 and bottomed at -$28.1 million in Q1 2023.
- A 5-year average of -$6.9 million and a median of -$13.7 million in 2025 frame the typical range for Free Cash Flow.
- Annual changes were most pronounced in 2023 — Free Cash Flow tumbled 327.52% — and 2024, when it surged 383.48%.
- Year by year, Free Cash Flow stood at -$25.6 million in 2022, then jumped by 266.29% to $42.6 million in 2023, then tumbled by 110.96% to -$4.7 million in 2024, then tumbled by 162.51% to -$12.2 million in 2025, then declined by 23.72% to -$15.1 million in 2026.
- The last three Free Cash Flow figures came in at -$15.1 million (Q1 2026), -$12.2 million (Q4 2025), and -$390000.0 (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Free Cash Flow (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 1,216,509.61 Bn | 1,216,509.61 Bn | - | -1.67 Mn |
| 2 | Alterity Therapeutics | 764,224.41 Bn | 764,224.38 Bn | - | - |
| 3 | Legend Biotech | 2,716.00 Bn | 2,715.71 Bn | 242.10 Mn | -12.20 Mn |
| 4 | Nanobiotix | 2,248.83 Bn | 2,248.77 Bn | - | - |
| 5 | Akari Therapeutics | 1,951.18 Bn | 1,951.17 Bn | - | -2.49 Mn |
| 6 | Vertex Pharmaceuticals | 113.69 Bn | 106.44 Bn | 2.59 Bn | 1.29 Bn |
| 7 | Evaxion A | 64.16 Bn | 64.14 Bn | - | - |
| 8 | Regeneron Pharmaceuticals | 63.94 Bn | 55.18 Bn | 3.31 Bn | 848.30 Mn |
| 9 | Alnylam Pharmaceuticals | 40.13 Bn | 37.12 Bn | 959.66 Mn | 48.67 Mn |
| 10 | Cellectis | 20.83 Bn | 20.62 Bn | - | -15.15 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -15.15 Mn |
| Mar 31, 2026 | -15.15 Mn |
| Dec 31, 2025 | -12.24 Mn |
| Dec 31, 2025 | -12.24 Mn |
| Sep 30, 2025 | -390,000.00 |
| Sep 30, 2025 | -390,000.00 |
| Jun 30, 2025 | -10.01 Mn |
| Jun 30, 2025 | -10.01 Mn |
| Mar 31, 2025 | -16.77 Mn |
| Mar 31, 2025 | -16.77 Mn |
| Dec 31, 2024 | -4.66 Mn |
| Dec 31, 2024 | -4.66 Mn |
| Sep 30, 2024 | -5.05 Mn |
| Sep 30, 2024 | -5.05 Mn |
| Jun 30, 2024 | 53.22 Mn |
| Jun 30, 2024 | 53.22 Mn |
| Mar 31, 2024 | -23.10 Mn |
| Mar 31, 2024 | -23.10 Mn |
| Dec 31, 2023 | 42.56 Mn |
| Dec 31, 2023 | 42.56 Mn |
| Sep 30, 2023 | -16.78 Mn |
| Sep 30, 2023 | -16.78 Mn |
| Jun 30, 2023 | -18.77 Mn |
| Jun 30, 2023 | -18.77 Mn |
| Mar 31, 2023 | -28.11 Mn |
| Mar 31, 2023 | -28.11 Mn |
| Sep 30, 2022 | -25.60 Mn |
| Sep 30, 2022 | -25.60 Mn |
| Jun 30, 2022 | -22.65 Mn |
| Jun 30, 2022 | -22.65 Mn |
| Mar 31, 2022 | -6.58 Mn |
| Mar 31, 2022 | -6.58 Mn |
| Sep 30, 2021 | -25.81 Mn |
| Sep 30, 2021 | -25.81 Mn |
| Jun 30, 2021 | -6.68 Mn |
| Jun 30, 2021 | -6.68 Mn |
| Mar 31, 2021 | -11.03 Mn |
| Mar 31, 2021 | -11.03 Mn |
| Dec 31, 2020 | -106.19 Mn |
| Dec 31, 2020 | -106.19 Mn |
| Sep 30, 2020 | -19.27 Mn |
| Sep 30, 2020 | -19.27 Mn |
| Jun 30, 2020 | -8.25 Mn |
| Jun 30, 2020 | -8.25 Mn |
| Mar 31, 2020 | 9.37 Mn |
| Mar 31, 2020 | 9.37 Mn |
| Dec 31, 2019 | -30.50 Mn |
| Dec 31, 2019 | -30.50 Mn |
| Sep 30, 2019 | -17.18 Mn |
| Sep 30, 2019 | -17.18 Mn |
| Jun 30, 2019 | -18.22 Mn |
| Jun 30, 2019 | -18.22 Mn |
| Mar 31, 2019 | -20.59 Mn |
| Mar 31, 2019 | -20.59 Mn |
| Dec 31, 2018 | -27.74 Mn |
| Dec 31, 2018 | -27.74 Mn |
| Sep 30, 2018 | -13.78 Mn |
| Sep 30, 2018 | -13.78 Mn |
| Jun 30, 2018 | -11.99 Mn |
| Jun 30, 2018 | -11.99 Mn |
| Mar 31, 2018 | -19.34 Mn |
| Mar 31, 2018 | -19.34 Mn |
| Dec 31, 2017 | -13.76 Mn |
| Dec 31, 2017 | -13.76 Mn |
| Sep 30, 2017 | -14.91 Mn |
| Sep 30, 2017 | -14.91 Mn |
| Jun 30, 2017 | -16.39 Mn |
| Jun 30, 2017 | -16.39 Mn |
| Mar 31, 2017 | -15.74 Mn |
| Mar 31, 2017 | -15.74 Mn |
| Dec 31, 2016 | -24.60 Mn |
| Dec 31, 2016 | -24.60 Mn |
| Sep 30, 2016 | 573,718.82 |
| Sep 30, 2016 | 573,718.82 |
| Jun 30, 2016 | -8.02 Mn |
| Jun 30, 2016 | -8.02 Mn |
| Mar 31, 2016 | -14.30 Mn |
| Mar 31, 2016 | -14.30 Mn |
| Dec 31, 2015 | 28.27 Mn |
| Dec 31, 2015 | 28.27 Mn |
| Sep 30, 2015 | -4.92 Mn |
| Sep 30, 2015 | -4.92 Mn |
| Jun 30, 2015 | -17.43 Mn |
| Jun 30, 2015 | -17.43 Mn |
| Mar 31, 2015 | 1.72 Mn |
| Mar 31, 2015 | 1.72 Mn |